The involvement of 5-HT3 and 5-HT4 receptors in two models of gastrointestinal transit in mice

This publication has 15 references indexed in Scilit:

• A Randomized Controlled Clinical Trial of the Serotonin Type 3 Receptor Antagonist Alosetron in Women With Diarrhea-Predominant Irritable Bowel Syndrome
  Archives of internal medicine (1960), 2001
• Role of Opioid Ligands in the Irritable Bowel Syndrome
  Canadian Journal of Gastroenterology and Hepatology, 1999
• 5‐HTP induced diarrhea as a carcinoid syndrome model in mice?
  Fundamental & Clinical Pharmacology, 1996
• RS 39604: a potent, selective and orally active 5‐HT₄ receptor antagonist
  British Journal of Pharmacology, 1995
• Effect of a 5HT₃‐antagonist (ondansetron) on rectal sensitivity and compliance in health and the irritable bowel syndrome
  Alimentary Pharmacology & Therapeutics, 1993
• 5-HT3 Receptor antagonists. 3. Quinoline derivatives which may be effective in the therapy of irritable bowel syndrome
  Journal of Medicinal Chemistry, 1993
• Short-circuit current responses to 5-hydroxytryptamine in human ileal mucosa are mediated by a 5-HT4 receptor
  European Journal of Pharmacology, 1993
• The Irritable Bowel Syndrome: Mechanisms and a Practical Approach to Management
  Annals of Internal Medicine, 1992
• A new method for measuring auricular inflammation in the mouse
  Journal of Pharmacological Methods, 1991
• Croton oil pleurisy induces pulmonary hyperreactivity
  Pharmacological Research Communications, 1988